AUPH Aurinia Pharmaceuticals Inc.
16.01USD+2.04%Mkt Cap: 2.13B $P/E: 7.021d ago
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYN…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap2.13B USD
Enterprise Value1.71B USD
Revenue (TTM)311.51M USD
Gross Profit250.39M USD
Net Income (TTM)287.20M USD
Revenue/Share2.37 USD
Last Price16.01 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees128
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)7.02
P/E (Forward)14.71
PEG—
EV/EBITDA9.50
EV/Revenue5.49
P/S6.70
P/B3.39
EPS (TTM)2.28
EPS (Forward)1.07
52W Range
10.9061% of range19.25
52W High19.25 USD
52W Low10.90 USD
Profitability
Gross Margin88.46%
Oper. Margin55.68%
EBITDA Margin57.73%
Profit Margin101.47%
ROE49.40%
ROA38.21%
Growth
Revenue Growth18.90%
Earnings Growth75.50%
Cash Flow & Leverage
Operating CF135.66M USD
CapEx (TTM)252.00K USD
FCF Margin47.45%
FCF Yield6.94%
Net Debt-378.89M USD
Net Debt/EBITDA-2.11
Balance Sheet
Debt/Equity0.13
Current Ratio5.42
Quick Ratio4.86
Book Value/Sh4.63 USD
Cash/Share3.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.86 USD
Upside (mean)+11.5%
Target Range16.00 USD – 21.00 USD
16.00+11.5% to mean21.00
# Analysts7
Ownership
Shares Out.133.05M
Float129.22M
Insiders6.79%
Institutions60.55%
Short Interest
Short Ratio9.2d
Short % Float7.12%
Short % Out.6.45%
Shares Short8.58M
Short (prev mo.)9.62M
Technical
SMA 5016.00 (+0.1%)
SMA 20015.56 (+2.9%)
Beta1.61
S&P 52W Chg16.45%
Avg Vol (30d)897.44K
Avg Vol (10d)804.66K
Technical Indicators
RSI (14)47.9
MACD-0.0472
MACD Signal0.0483
MACD Hist.-0.0955
BB Upper16.91 USD
BB Middle16.25 USD
BB Lower15.60 USD
BB Width8.07%
ATR (14)0.4460 USD
Vol Ratio (20d)0.84x